Has Fekade Tefera, MD received payments from drug or device companies?

Yes. Drug and device makers reported $424 in general payments to Fekade Tefera, MD across 5 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Fekade Tefera, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Fekade Tefera, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Fekade Tefera, MD

Nephrology · Brooklyn, NYNPI 1336177328

Payments from drug & device makers

$424in general payments, 2019–2025

Across 5 payments — averaging $84.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Vifor Pharma, Inc.$154
Otsuka America Pharmaceutical, Inc.$125
Mallinckrodt Enterprises LLC$123
AstraZeneca$22

What the payments were for

Food & beverage$424100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Vifor Pharma, Inc.	2	$154
Otsuka America Pharmaceutical, Inc.	1	$125
Mallinckrodt Enterprises LLC	1	$123
AstraZeneca	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

JYNARQUE$125
ACTHAR$123

How this compares

$424 in reported general payments places this provider in the 40th percentile of 935 nephrology providers in New York.

See all nephrology providers in New York →

Medicare billing

Part B allowed, 2024

$335,121

Medicare patients

175

Services billed

2,269

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	35	$28,800
JanuviaSitagliptin Phosphate	19	$20,213
Sevelamer Carbonate	34	$3,018
Calcium Acetate	44	$2,625
Nifedipine ErNifedipine	98	$1,955
Losartan Potassium	133	$1,443
Metoprolol Succinate	95	$863
Hydralazine Hcl	29	$517
Simvastatin	68	$424
Atorvastatin Calcium	52	$412
Albuterol Sulfate HfaAlbuterol Sulfate	14	$392
Labetalol Hcl	11	$374
Metformin Hcl	52	$270
Telmisartan	13	$266
Omeprazole	40	$238

Paid to pharmacies, not to this prescriber.

Other nephrology in Brooklyn

Subodh SaggiBrooklyn$419K
Alexander SwanBrooklyn$172K
Joji TokitaNew York$8.4M
Krzysztof KirylukNew York$6.7M
David BernardNew York$6M
Andrew BombackNew York$3.4M
Pietro CanettaNew York$3.2M
Robert LynnBronx$2M
Jodumutt BhatMaspeth$1.5M
Gerald AppelNew York$1.5M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →